Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Inno-Gene financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$81.2
2024-10-29
Market Capitalization
$138 M
2024-10-29
Revenue
ZŁ3.3 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| PLN | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 2.8M | 1.4M | 4.7M | 29.9M | 16.4M | 1.1M | 3.3M |
| Cost of goods sold | 1.3M | 665.0K | 2.0M | 15.2M | 8.7M | 1.8M | 574.0K |
| Gross profit | 2.2M | 1.6M | 3.3M | 15.8M | 8.4M | (581.0K) | 2.8M |
| Gross profit margin, % | 79.6% | 114.8% | 71.5% | 53.0% | 51.2% | -51.5% | 85.2% |
| Operating expense total | 1.0M | 998.0K | 928.0K | 5.2M | 6.4M | 1.8M | 1.2M |
| Depreciation and amortization | 796.0K | 872.0K | 944.0K | 1.0M | 95.0K | 152.0K | 76.0K |
| EBITDA | 1.2M | 560.0K | 2.9M | 10.5M | 2.5M | (4.5M) | 163.0K |
| EBITDA margin, % | 43.5% | 41.3% | 63.0% | 35.1% | 15.1% | -396.5% | 4.9% |
| EBIT | 435.0K | (312.0K) | 2.0M | 9.4M | 2.4M | (4.6M) | 87.0K |
| EBIT margin, % | 15.4% | -23.0% | 42.8% | 31.6% | 14.5% | -410.0% | 2.6% |
| Interest income | 3.0K | 21.0K | 1.2M | 1.1M | |||
| Interest expense | 114.0K | 17.0K | 292.0K | 25.0K | 11.0K | 15.0K | 19.0K |
| Pre tax profit | 324.0K | (272.0K) | 1.7M | 8.5M | 768.0K | (5.3M) | 95.0K |
| Income tax expense | 24.0K | 14.0K | 211.0K | 2.4M | 453.0K | 901.0K | 76.0K |
| Net Income | 300.0K | (286.0K) | 1.5M | 6.1M | 315.0K | (6.2M) | 19.0K |